A total of 760 subjects were examined, giving a response rate of 96.8%. Three hundred fifty-five (46.7%) were males and 405(53.3%) were females. The mean age was 54 (SD 9.74) (range 40– 90) years. Table 1 shows the age and sex distribution of the study subjects.
Table 1. Distribution of the study subjects by age and sex, prevalence of PXF among adults in Kebena Woreda, Gurage zone; January 2017
Age range
|
Male
n (% column)
|
Men with PXF n (% row)
|
Female
n (% column)
|
Women with PXF
n (% row)
|
Total no of subjects examined
n (% row)
|
|
40-49
|
98 (27.6%)
|
1 (1.0%)
|
94 (23.2%)
|
1 (1.1%)
|
192 (25.3%)
|
|
50-59
|
127 (35.8%)
|
8 (6.3%)
|
196(48.4%)
|
15 (7.7%)
|
323 (42.5%)
|
|
60-69
|
86 (24.2%)
|
12 (14.0%)
|
95(23.5%)
|
23 (24.2%)
|
181 (23.8%)
|
|
70-79
|
38 (10.7%)
|
21 (55.3%)
|
18 (4.4%)
|
6 (33.3%)
|
56 (7.4%)
|
|
80-90
|
6 (1.7%)
|
2 (33.3%)
|
2 (0.5%)
|
2 (100.0%)
|
8 (1.1%)
|
|
Total
|
355 (100% )
|
44 (12.4%)
|
405 (100%)
|
47 (11.6%)
|
760 (100%)
|
Of the total eligible population (760 subjects), 93 were found to have pseudoexfoliation in one or both eyes, a prevalence of 12.2% (95% CI: 9.7% -14.3%). Of the 93 participants with PXF, 51(56%) were found to have bilateral pseudoexfoliation (95% CI: 46% – 66%).
The mean age of participants with PXF was 63.9 years (SD 9.962, age range 40-90 years), while it was 52.63 (SD 8.90, range 40-90 years) for those without PXF. The difference was found to be statistically significant (95% CI: 9.18% – 13.11%, P = 0.00)
Prevalence of PXF increased with age (X2 test; P = 0.000) and was highest among subjects aged > 70 years. Sixty-six (26.9%) of subjects of 60 years or older had PXF in one or both eyes and 50% of subjects above the age of 70 were found to have pseudoexfoliation. Age-specific prevalence rates are shown in Table 2.
Table 2. Prevalence of PXF according to age among adults in Kebena woreda, Gurage zone: January 2017.
Age range
|
No. examined
|
Unilateral PXF
n (% row)
|
PXF in OD &
OS
n (% row)
|
PXF in one or both eyes, n (% row)
|
OR (95% CI) for PXF in one or both eyes
|
P
|
40-50
|
360
|
7(1.9%)
|
4 (1.1%)
|
11 (3.1%)
|
1.00
|
0.000
|
51-60
|
283
|
19 (6.7%)
|
19 (6.7%)
|
38 (13.4%)
|
4.7 (3.7- 9.7)
|
0.000
|
61-70
|
73
|
8 (11.0%)
|
14 (19.2%)
|
22 (30.1%)
|
6.5 ( 3.3 - 12.8)
|
0.000
|
71-90
|
44
|
8 (18.2%)
|
14 (31.8%)
|
22 (50.0%)
|
2.3 (1.1- 5.1)
|
0.033
|
TOTAL
|
760
|
42(5.5%)
|
51 (6.7%)
|
93 (12.2%)
|
|
|
Odds ratios for the likelihood of developing either unilateral or bilateral pseudoexfoliation syndrome, by age are also displayed in the table with the 40 - 50 year age group as reference. The older groups all had significantly higher ORs than the reference group.
Slightly higher proportion of males (12.4%) were found to have pseudoexfoliation in either of the eyes than females (11.6%) which was not statistically significant (p=0.738), even after Standardization for age differences (p=0.317; age adjusted odds ratio, 1.29; 95% confidence interval, 0.79 to 2.11).
Features of PXF
In 68 eyes (47.2%), deposits were visible only at the pupillary border, while in 14 (9.7%) deposits could seen only on the anterior lens capsule. Deposits were present both at the pupillary border and on the anterior lens capsule in 62 eyes (43%).
Intraocular Pressure
The mean IOP of the right eye in the PXF population was 20.65(SD 5.15) (range 12-45) mmHg and 15.0(SD 2.30) (range 10-40) mmHg for the non-pseudoexfoliators. The mean difference of 5.65 mmHg between the two populations was found to be statistically significant (95% CI 4.05 to 6.50 mmHg; p< 0.0001).
The mean IOP of the left eye in the PXF population was 21.69(SD 5.58) (range 12-39) mmHg and 15.50(SD 1.90) (range 10-24) mmHg for the non-pseudoexfoliators. The mean difference of 6.19 mmHg between the two populations was statistically significant (95% CI 4.88 to 7.51 mmHg; p<0.0001).
The mean IOP of the eye with PXF in subjects with unilateral PXF was 19.45 (SD 3.78) mmHg and, bilateral PXF eyes had a mean IOP of 21.75 (SD 5.73) mmHg. But the mean difference of 1.70 mmHg between the two populations was not statistically significant (95% CI 0.20 to 3.67 mmHg; p = 0.053).
Fifty (34.7%) eyes with PXF syndrome had IOP higher than 21 mm Hg. And only 12 (0.8%) of eyes without PXF were found to have IOP >21 mmHg.
Cataract was found in 59.2% of eyes with PXF, but in only 13.5% of Non-PXF eyes (p < 0.001), indicating a strong association between cataract and PXF.
Table 3 presents data on the association between pseudoexfoliation and senile lens changes for right and left eye. In a univariate analysis nuclear and posterior subcapsular cataract were found to be significantly associated with pseudoexfoliation. (p=0.03) But when adjusted for age, the association becomes statistically insignificant.
Table 3. The association between Pseudoexfoliation and senile lens changes for right and left eye among adults in Kebena Woreda, Gurage zone: January 2017
Status Of Lens
|
PXF in the right eye
n (%)
|
PXF in the left eye
n (%)
|
Clear
|
15(30.8%)
|
14(19.4%)
|
|
Nuclear cataract
|
8(11.1%)
|
10(13.9%)
|
|
Cortical cataract
|
18(25.0%)
|
20(27.8%)
|
|
Nuclear + PSC
|
16(22.2%)
|
12(16.7%)
|
|
Dense
|
15(20.8%)
|
16(22.2%)
|
|
Total
|
72(100.0%)
|
72(100.0%)
|
|
Forty eight (33.3%, 95% CI: 20.0 – 41.2) eyes with PXF had Best Village-Based distance visual acuity of <6/60. The prevalence of low vision and blindness in the study population was 0.5 % and 1.7 % respectively. But among subjects with PXF, 0.9 % and 2.3% had blindness and low vision. The prevalence of impaired vision in the involved eye was significantly higher in subjects with PXF (age adjusted OR, 4.55; 95% CI: 2.26 – 9.18).